FARHAN FAZAL: Open Payments
NPI 1912162611 · HAZARD, KY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$313 in 15 payments from 8 companies in 2025. Trend: 2023 $476 · 2024 $422 · 2025 $313
Food & beverage: $313
| Company | Payments | Amount |
|---|---|---|
| E.R. Squibb & Sons, L.L.C. | 3 | $86 |
| Axsome Therapeutics, Inc. | 3 | $59 |
| Alkermes, Inc. | 2 | $42 |
| Vanda Pharmaceuticals Inc. | 2 | $38 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 2 | $32 |
| Indivior Inc. | 1 | $21 |
| Lundbeck LLC | 1 | $19 |
| Janssen Pharmaceuticals, Inc | 1 | $16 |
Products named: COBENFY, Auvelity, LYBALVI, HETLIOZ, CAPLYTA, SUBLOCADE, ABILIFY ASIMTUFII, SPRAVATO.
Industry payments across KY — which companies pay providers there.
